Bristol, United Kingdom

Patricia Kuwabara


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Patricia Kuwabara

Introduction: Patricia Kuwabara, a renowned inventor based in Bristol, GB, has made significant contributions to the field of cancer research. With her inventive spirit and commitment to advancing medical science, she has developed a pioneering patent that addresses critical challenges in cancer treatment.

Latest Patents: Patricia holds a key patent titled "Peptide inhibitors of IASPP." This innovative invention relates to a polypeptide or part thereof, which plays a crucial role in inhibiting the apoptotic activity of the tumor suppressor protein p53. Her patent also encompasses screening methods designed to identify agents that interfere with the activity of this essential polypeptide.

Career Highlights: Patricia has had an illustrious career, working with prestigious research organizations dedicated to advancing scientific knowledge. She has been associated with the Ludwig Institute for Cancer Research Limited and Genome Research Limited, where her research has focused on the intersection of proteins and cancer.

Collaborations: Throughout her career, Patricia has collaborated with eminent scientists, including Xin Lu and David Lawrence Selwood. These partnerships have enriched her research and contributed to the successful development of her innovative inventions.

Conclusion: Patricia Kuwabara stands out as a formidable inventor in the realm of medical research. Her innovative approach to developing peptide inhibitors of IASPP signifies her dedication to combating cancer and underscores her impactful role in scientific advancement. As she continues to explore new ideas and technologies, she remains a key figure in the fight against cancer, inspiring future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…